Alerts will be sent to your verified email
Verify EmailPFIZER
Pfizer
|
Jubilant Pharmova
|
Strides Pharma Scien
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
Domestic Sales Growth - YoY
|
-7.9 % | n/a | n/a |
Financials
|
|||
5 yr Average ROE
|
18.17 % | 10.45 % | -1.06 % |
5yr average Equity Multiplier
|
1.31 | 2.05 | 2.7 |
5yr Average Asset Turnover Ratio
|
0.6 | 0.64 | 0.45 |
5yr Avg Net Profit Margin
|
23.14 % | 8.17 % | 0.77 % |
Price to Book
|
5.95 | 1.98 | 4.01 |
P/E
|
38.75 | 283.16 | 0.0 |
5yr Avg Cash Conversion Cycle
|
-26.61 Days | -3.54 Days | -89.35 Days |
Inventory Days
|
48.38 Days | 78.49 Days | 71.49 Days |
Days Receivable
|
20.98 Days | 54.89 Days | 73.25 Days |
Days Payable
|
83.8 Days | 167.25 Days | 261.28 Days |
5yr Average Interest Coverage Ratio
|
173.5 | 4.68 | 0.64 |
5yr Avg ROCE
|
23.74 % | 10.85 % | 6.23 % |
5yr Avg Operating Profit Margin
|
35.56 % | 20.24 % | 14.43 % |
5 yr average Debt to Equity
|
0.0 | 0.71 | 1.04 |
5yr CAGR Net Profit
|
69.5 % | n/a | n/a |
5yr Average Return on Assets
|
13.93 % | 5.11 % | -0.26 % |
Shareholdings
|
|||
Promoter Holding
|
63.92 % | 50.68 % | 25.88 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 72.7 % |
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -3.79 % |
Change in Mutual Fund Holding (3 Yrs)
|
-0.7 % | 1.49 % | -4.24 % |
Pfizer
|
Jubilant Pharmova
|
Strides Pharma Scien
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|